Quinoxaline-2,3-diol; Quinoxaline-2,3(1H,4H)-dione; 2,3-QUINOXALINEDIOL; 1,4-Dihydro-2,3-quinoxalinedione; 2,3-Quinoxalinedione, 1,4-dihydro-; 1,4-dihydroquinoxaline-2,3-dione; USAF EK-6232; 2,3(1H,4H)-Quinoxalinedione; Quinoxaline, 2,3-dihydroxy-; NSC 8698; 1,4-Dihydro-quinoxaline-2,3-dione; EINECS 239-901-0; MFCD00006723; UNII-APO55IZ9E1; APO55IZ9E1; AI3-03736; CHEMBL282672; 1,3-quinoxalinedione; 1,2,3,4-tetrahydroquinoxaline-2,3-dione; Quinoxaline,3-dihydroxy-; WLN: T66 BN ENJ CQ DQ; hydroxyquinoxalone; ACMC-209xgn; 2,3-Dihydroxyphenpiazine; ACMC-1B2H3; KSC497G8N; MLS000681641; SCHEMBL239920; ARONIS014393; DTXSID9065946; 2,3-Dihydroxyquinoxaline, 98%; CTK3J7386; KS-00000MLG; NSC8698; NSC9431; Quinoxalin-2,3(1H,4H)-Dione; 2,3(1H, 4H)-Quinoxalinedione; HMS2750H11; KUC106696N; NSC-8698; NSC-9431; 1,4-Dihydro quinoxaline-2,3-dione; 8041AF; ANW-21746; ANW-47637; BBL004435; BBL009202; BDBM50008752; CCG-49235; SBB000138; STK264174; STL125448; ZINC18182210; AKOS000503008; AKOS001280678; AB06251; MCULE-6753530638; NE10454; CIS-11-EICOSENOICACIDMETHYLESTER; KS-000044U8; NCGC00245941-01; 2(1H), 3(4H)-QUINOXALINEDIONE; AK-45516; BR-45516; KSC-11-207-7; SMR000312325; ST003022; DB-043375; LS-143031; AM20070315; BB 0242095; BB 0258963; D1010; EU-0000335; FT-0609673; FT-0609674; FT-0691401; W3434; K-4961; 10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.2; 804D190; AA-516/30054034; SR-01000391115; doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.2; SR-01000391115-1; SR-01000391115-2; W-107998; F0266-0994